Ligand validation:2E56

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 2E56 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2E56_MYR_A_701	19%	58%	0.227	0.823	0.58	1	-	1	3	0	100%	1
2E56_MYR_A_501	15%	60%	0.225	0.781	0.58	0.94	-	-	1	0	100%	1
2E56_MYR_A_601	4%	59%	0.269	0.626	0.59	0.96	-	2	1	0	100%	1
4G8A_MYR_D_205	51%	57%	0.189	0.956	0.86	0.81	1	-	0	0	94%	0.9375
3FXI_MYR_B_1008	7%	62%	0.41	0.886	0.23	1.21	-	2	0	0	94%	0.9375
8Q2Z_MYR_C_201	93%	68%	0.081	0.975	0.46	0.77	-	-	0	0	100%	0.9375
6NOK_MYR_A_401	92%	52%	0.077	0.967	0.71	1.14	-	2	0	0	100%	1
8Q3D_MYR_D_101	92%	65%	0.086	0.975	0.53	0.81	-	-	0	0	100%	0.9375
7OWO_MYR_D_401	88%	73%	0.088	0.962	0.45	0.59	-	-	0	0	100%	0.525
8Q3T_MYR_C_201	87%	69%	0.092	0.965	0.47	0.72	-	-	0	0	100%	0.9375

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.